BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Stem Cells. Aug 26, 2026; 18(8): 121124
Published online Aug 26, 2026. doi: 10.4252/wjsc.121124
Stem/progenitor cell-driven immune microenvironment remodeling in sepsis-associated acute respiratory distress syndrome
Si-Cong Jiang, Sheng-Li Fan, Yu-Xuan Xing, Lei Gong, Wen-Xing Li
Wen-Xing Li, Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
Wen-Xing Li, Department of Anesthesiology, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
Wen-Xing Li, Department of Anesthesiology, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Si-Cong Jiang, Division of Thoracic and Endocrine Surgery, University Hospitals and University of Geneva, Geneva 1211, Switzerland
Sheng-Li Fan, Department of Pharmacy, Shanxi Pharmaceutical Vocational College, Taiyuan 030602, Shanxi Province, China
Yu-Xuan Xing, Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu Province, China
Lei Gong, Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
Lei Gong, Department of Esophageal Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
Lei Gong, Department of Esophageal Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, China
Author contributions: Li WX and Jiang SC contributed equally to this study and are co-first authors. Li WX and Jiang SC contributed to conceptualization, investigation, and data curation; Jiang SC, Fan SL, Xing YX, and Gong L contributed to writing, review, and editing; Li WX contributed to methodology and writing of the original draft; Fan SL contributed to formal analysis and visualization; Xing YX contributed to data collection and literature search; Gong L contributed to supervision, project administration, and funding acquisition; and all authors have read and approved the final version of the manuscript.
AI contribution statement: We did not use AI tools to participate in the generation of research data, interpretation of results, or formulation of conclusions. The author rigorously reviewed and revised all outputs generated by AI.
Institutional review board statement: This study was approved by the Medical Ethics Committee of Tianjin Medical University Cancer Institute and Hospital, No. 2026-01-33.
Informed consent statement: Owing to the retrospective nature of the study and the use of anonymized data, the requirement for informed consent was waived by the ethics committee.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Corresponding author: Lei Gong, PhD, Associate Chief Physician, Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu West Road, Hexi District, Tianjin 300060, China. pear0721@163.com
Received: April 10, 2026
Revised: May 12, 2026
Accepted: June 22, 2026
Published online: August 26, 2026
Processing time: 131 Days and 22.2 Hours
Abstract
BACKGROUND

Sepsis-associated acute respiratory distress syndrome (ARDS) is characterized by diffuse alveolar epithelial injury, dysregulated immune activation, and impaired inflammation resolution. Alveolar epithelial stem/progenitor cells are critical for restoring alveolar integrity; however, their phenotypic changes and association with local and systemic immune microenvironments remain insufficiently defined.

AIM

To investigate the relationship between phenotypic changes in alveolar epithelial stem cells/progenitor cells and the immune microenvironment imbalance in sepsis-associated ARDS and evaluate its correlation with the severity of the disease and intensive care unit (ICU) outcomes and to provide a basis for individualized intervention based on epithelial repair and immune regulation.

METHODS

A total of 200 patients with sepsis-ARDS who were admitted to the ICU of Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, from January 2023 to December 2025, were retrospectively included. They were divided into a moderate group (n = 111) and a severe group (n = 89) according to Berlin’s criteria. Bronchoalveolar lavage fluid (BALF) and peripheral blood were collected within 48 hours after tracheal intubation. Quantitative polymerase chain reaction was used to detect the relative expression of alveolar epithelial type II cells progenitor cell marker surfactant protein C (SFTPC) in BALF cell pellets, and the proportion of epithelial cell adhesion molecule and CD44-positive cells was determined by flow cytometry. The T helper 17 cells (Th17)/regulatory T cells (Treg) ratio in BALF, the ratio of CD4+/CD8+ T cells, and plasma interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and IL-10 were detected simultaneously. Blood lactate, ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2), sequential organ failure assessment (SOFA)/acute physiology and chronic health evaluation II scores, and duration of mechanical ventilation, ICU stay, and 28-day mortality were recorded.

RESULTS

In the severe group, SOFA, acute physiology and chronic health evaluation II, and lactic acid levels significantly increased, whereas PaO2/FiO2 decreased (all P < 0.001). Compared with the moderate group, the severe group had significantly decreased SFTPC and epithelial cell adhesion molecule, and increased CD44 (P < 0.001); the Th17/Treg ratio was increased, but the proportion of CD4+ T cells was decreased, and the proportion of CD8+ T cells was increased. IL-6 and tumor necrosis factor-α were significantly increased (P < 0.05). Correlation analysis showed that SFTPC was negatively correlated with Th17/Treg, IL-6, and lactic acid levels and positive correlated with PaO2/FiO2 (r = 0.510, P < 0.001). Multivariate logistic regression analysis indicated that SOFA (odds ratio = 1.33, P = 0.005) and SFTPC (odds ratio = 0.03, P = 0.002) were independent predictors of 28-day mortality.

CONCLUSION

The phenotypic decline of alveolar epithelial type II cells progenitor cells in sepsis-ARDS is associated with an imbalance in T cell subsets and increased levels of inflammatory factors, which are also closely related to oxygenation disorders and adverse outcomes. Epithelial repair-related indicators such as SFTPC can be used for risk stratification and suggest potential avenues for translational intervention.

Keywords: Sepsis; Acute respiratory distress syndrome; Alveolar epithelial type II cells; Progenitor cells; Inflammatory factors; Lactic acid; Prognosis

Core Tip: In sepsis-acute respiratory distress syndrome, the downregulation of alveolar epithelial type II cells progenitor markers (surfactant protein C, epithelial cell adhesion molecule) is accompanied by T-cell subset imbalance and elevated proinflammatory cytokines, which are closely associated with disease severity, oxygenation impairment and increased lactate; surfactant protein C and sequential organ failure assessment score are independent predictors of 28-day mortality, suggesting that stem/progenitor cell-mediated immune microenvironment remodeling may serve as a promising prognostic indicator and therapeutic target for sepsis-acute respiratory distress syndrome.

Write to the Help Desk